255 related articles for article (PubMed ID: 32651994)
1. Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study.
Li YF; Zhang QQ; Wang WL
Med Sci Monit; 2020 Jul; 26():e923375. PubMed ID: 32651994
[TBL] [Abstract][Full Text] [Related]
2. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
4. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of small-cell versus large-cell gastroenteropancreatic neuroendocrine carcinomas: A population-based study.
Abdel-Rahman O; Fazio N
J Neuroendocrinol; 2021 May; 33(5):e12971. PubMed ID: 33870570
[TBL] [Abstract][Full Text] [Related]
7. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
Lv Y; Han X; Xu XF; Ji Y; Zhou YH; Sun HC; Zhou J; Fan J; Lou WH; Huang C
BMC Cancer; 2019 Apr; 19(1):335. PubMed ID: 30961559
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.
Yi Z; Liu R; Hu J; He T; Wang Z; Li Y; Zu X
Clin Genitourin Cancer; 2021 Apr; 19(2):155-161. PubMed ID: 33288452
[TBL] [Abstract][Full Text] [Related]
9. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
10. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis.
Li J; Lin Y; Wang Y; Lin H; Lin F; Zhuang Q; Lin X; Wu J
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32253246
[TBL] [Abstract][Full Text] [Related]
11. Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients.
Baeg K; Harris C; Naparst MS; Ahn E; Thapi S; Martin J; Rustgi S; Mhango G; Wisnivesky J; Kim MK
BMC Cancer; 2021 Feb; 21(1):146. PubMed ID: 33563241
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
[TBL] [Abstract][Full Text] [Related]
13. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort.
Lithgow K; Venkataraman H; Hughes S; Shah H; Kemp-Blake J; Vickrage S; Smith S; Humphries S; Elshafie M; Taniere P; Diaz-Cano S; Dasari BVM; Almond M; Ford S; Ayuk J; Shetty S; Shah T; Geh I
Sci Rep; 2021 Sep; 11(1):17947. PubMed ID: 34504148
[TBL] [Abstract][Full Text] [Related]
14. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
Xu B; Chu Y; Hu Q; Song Q
Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
[TBL] [Abstract][Full Text] [Related]
16. The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients: A population based analysis.
Wang S; Zhang J; Liu S; Zhang J
Medicine (Baltimore); 2019 Nov; 98(44):e17773. PubMed ID: 31689842
[TBL] [Abstract][Full Text] [Related]
17. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract][Full Text] [Related]
18. Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Zhou H; Zhang Y; Song Y; Tan W; Qiu Z; Li S; Chen Q; Gao S
Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):476-486. PubMed ID: 28416359
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs.
Chen L; Zhou L; Zhang M; Shang L; Zhang P; Wang W; Fang C; Li J; Xu T; Tan H; Zhang P; Qiu M; Yu X; Jin K; Chen Y; Chen H; Lin R; Zhang Q; Shen L; Chen M; Li J; Li L; Chen J
BMC Cancer; 2017 Aug; 17(1):521. PubMed ID: 28778195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]